Patients carrying an inactive NF1 allele develop tumors of Schwann cell origin called neurofi bromas (NF). Genetically engineered mouse models have signifi cantly enriched our understanding of plexiform forms of NFs (pNF). However, this has not been the case for cutaneous neurofi bromas (cNF), observed in all NF1 patients, as no previous model recapitulates their development. Here, we show that conditional Nf1 inactivation in Prss56-positive boundary cap cells leads to bona fi d e pNFs and cNFs. This work identifi es subepidermal glia as a likely candidate for the cellular origin of cNFs and provides insights on disease mechanisms, revealing a long, multistep pathologic process in which infl ammation-related signals play a pivotal role. This new mouse model is an important asset for future clinical and therapeutic investigations of NF1-associated neurofi bromas. SIGNIFICANCE: Patients affected by NF1 develop numerous cNFs. We present a mouse model that faithfully recapitulates cNFs, identify a candidate cell type at their origin, analyze the steps involved in their formation, and show that their development is dramatically accelerated by skin injury. These fi ndings have important clinical/therapeutic implications.